Search research articles
Contact Us
Filters
Showing results (81-90 of 113) with videos related to
Page
of 12
Sort By:
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
May 21, 2016
Systemic Treatment of Metachronous Metastases After Curative Treatment of Breast Cancer
J G Kuiper, M P P van Herk-Sukel, Y R B M van Gestel, et al.
International Journal of Cancer
|
November 13, 2020
Risk of cardiovascular disease following gonadotropin-releasing hormone agonists vs antagonists in prostate cancer: Real-world evidence from five databases
Gincy George, Hans Garmo, Lucie-Marie Scailteux, et al.
Clinical Therapeutics
|
March 29, 2017
Use of Lipid-modifying Therapy and LDL-C Goal Attainment in a High-Cardiovascular-Risk Population in the Netherlands
Josephina G Kuiper, Robert J Sanchez, Eline Houben, et al.
Diabetes, Obesity & Metabolism
|
December 12, 2018
How representative of a general type 2 diabetes population are patients included in cardiovascular outcome trials with SGLT2 inhibitors? A large European observational study
Kåre I Birkeland, Johan Bodegard, Anna Norhammar, et al.
Molecular Endocrinology (Baltimore, Md.)
|
October 1, 1991
Substitution of aspartic acid-686 by histidine or asparagine in the human androgen receptor leads to a functionally inactive protein with altered hormone-binding characteristics
C Ris-Stalpers, M A Trifiro, G G Kuiper, et al.
Nederlands Tijdschrift Voor Geneeskunde
|
June 15, 2017
[Fosfomycin, an old antibiotic with new possibilities]
A C Dijkmans, S G Kuiper, J Burggraaf, et al.
The Journal of Steroid Biochemistry and Molecular Biology
|
January 1, 1991
Androgen receptor abnormalities
A O Brinkmann, G G Kuiper, C Ris-Stalpers, et al.
Endocrinology
|
September 29, 1998
Interaction of estrogenic chemicals and phytoestrogens with estrogen receptor beta
G G Kuiper, J G Lemmen, B Carlsson, et al.
Fundamental & Clinical Pharmacology
|
February 19, 2019
Real-world insights into risk of developing cardiovascular disease following GnRH agonists versus antagonists for prostate cancer: a methodological protocol to a study using five European databases
Gincy George, Lucie-Marie Scailteux, Hans Garmo, et al.
The Journal of Clinical Endocrinology and Metabolism
|
April 21, 2005
Neuroanatomical pathways for thyroid hormone feedback in the human hypothalamus
Anneke Alkemade, Edith C Friesema, Unga A Unmehopa, et al.
Page
of 12
Search research articles
Search
Showing results (81-90 of 113) with videos related to
Sort By:
Page
of 12
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
May 21, 2016
Systemic Treatment of Metachronous Metastases After Curative Treatment of Breast Cancer
J G Kuiper, M P P van Herk-Sukel, Y R B M van Gestel, et al.
International Journal of Cancer
|
November 13, 2020
Risk of cardiovascular disease following gonadotropin-releasing hormone agonists vs antagonists in prostate cancer: Real-world evidence from five databases
Gincy George, Hans Garmo, Lucie-Marie Scailteux, et al.
Clinical Therapeutics
|
March 29, 2017
Use of Lipid-modifying Therapy and LDL-C Goal Attainment in a High-Cardiovascular-Risk Population in the Netherlands
Josephina G Kuiper, Robert J Sanchez, Eline Houben, et al.
Diabetes, Obesity & Metabolism
|
December 12, 2018
How representative of a general type 2 diabetes population are patients included in cardiovascular outcome trials with SGLT2 inhibitors? A large European observational study
Kåre I Birkeland, Johan Bodegard, Anna Norhammar, et al.
Molecular Endocrinology (Baltimore, Md.)
|
October 1, 1991
Substitution of aspartic acid-686 by histidine or asparagine in the human androgen receptor leads to a functionally inactive protein with altered hormone-binding characteristics
C Ris-Stalpers, M A Trifiro, G G Kuiper, et al.
Nederlands Tijdschrift Voor Geneeskunde
|
June 15, 2017
[Fosfomycin, an old antibiotic with new possibilities]
A C Dijkmans, S G Kuiper, J Burggraaf, et al.
The Journal of Steroid Biochemistry and Molecular Biology
|
January 1, 1991
Androgen receptor abnormalities
A O Brinkmann, G G Kuiper, C Ris-Stalpers, et al.
Endocrinology
|
September 29, 1998
Interaction of estrogenic chemicals and phytoestrogens with estrogen receptor beta
G G Kuiper, J G Lemmen, B Carlsson, et al.
Fundamental & Clinical Pharmacology
|
February 19, 2019
Real-world insights into risk of developing cardiovascular disease following GnRH agonists versus antagonists for prostate cancer: a methodological protocol to a study using five European databases
Gincy George, Lucie-Marie Scailteux, Hans Garmo, et al.
The Journal of Clinical Endocrinology and Metabolism
|
April 21, 2005
Neuroanatomical pathways for thyroid hormone feedback in the human hypothalamus
Anneke Alkemade, Edith C Friesema, Unga A Unmehopa, et al.
Page
of 12